Legis Daily

IGNITE American Innovation Act

USA117th CongressS-2529| Senate 
| Updated: 7/29/2021
Robert Menendez

Robert Menendez

Democratic Senator

New Jersey

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Innovation and Growth Now by Investing in Tomorrow's Enterprises Act or the IGNITE American Innovation Act This bill allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net operating loss carryovers arising during 2015 through 2021. The bill allows an increased research tax credit for COVID-19 research expenditures paid or incurred on or after February 15, 2020, and before January 1, 2022.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2021

Latest Companion Bill Action

HR 117-3623
Introduced in House
Jul 29, 2021
Introduced in Senate
Jul 29, 2021
Read twice and referred to the Committee on Finance.
  • May 28, 2021

    Latest Companion Bill Action

    HR 117-3623
    Introduced in House


  • July 29, 2021
    Introduced in Senate


  • July 29, 2021
    Read twice and referred to the Committee on Finance.

Taxation

Related Bills

  • HR 117-3623: IGNITE American Innovation Act
Business expensesCardiovascular and respiratory healthCorporate finance and managementDisability assistanceDrug therapyEmergency medical services and trauma careHealth promotion and preventive careHealth technology, devices, suppliesIncome tax creditsIncome tax deductionsInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsPrescription drugsResearch and development

IGNITE American Innovation Act

USA117th CongressS-2529| Senate 
| Updated: 7/29/2021
Innovation and Growth Now by Investing in Tomorrow's Enterprises Act or the IGNITE American Innovation Act This bill allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net operating loss carryovers arising during 2015 through 2021. The bill allows an increased research tax credit for COVID-19 research expenditures paid or incurred on or after February 15, 2020, and before January 1, 2022.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2021

Latest Companion Bill Action

HR 117-3623
Introduced in House
Jul 29, 2021
Introduced in Senate
Jul 29, 2021
Read twice and referred to the Committee on Finance.
  • May 28, 2021

    Latest Companion Bill Action

    HR 117-3623
    Introduced in House


  • July 29, 2021
    Introduced in Senate


  • July 29, 2021
    Read twice and referred to the Committee on Finance.
Robert Menendez

Robert Menendez

Democratic Senator

New Jersey

Finance Committee

Taxation

Related Bills

  • HR 117-3623: IGNITE American Innovation Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business expensesCardiovascular and respiratory healthCorporate finance and managementDisability assistanceDrug therapyEmergency medical services and trauma careHealth promotion and preventive careHealth technology, devices, suppliesIncome tax creditsIncome tax deductionsInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsPrescription drugsResearch and development